TD Cowen Downgrades GlycoMimetics to Hold
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Boris Peaker has downgraded GlycoMimetics (NASDAQ:GLYC) from Buy to Hold.
July 26, 2024 | 6:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
TD Cowen analyst Boris Peaker has downgraded GlycoMimetics from Buy to Hold, which may indicate a less optimistic outlook for the company's stock performance.
The downgrade from Buy to Hold by a reputable analyst suggests a shift in sentiment towards GlycoMimetics, which could lead to a short-term decline in the stock price as investors adjust their expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100